Bioforce Nanosciences Holdings (BFNH) Total Current Liabilities (2020 - 2026)

Bioforce Nanosciences Holdings has disclosed Total Current Liabilities across 7 years of filings, most recently posting $727301.0 for Q1 2026.

• Quarterly Total Current Liabilities rose 164.43% year-over-year to $727301.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $727301.0 (up 164.43% YoY) and the FY2025 annual result came in at $619329.0, down 73.1% from the prior year.
• Total Current Liabilities grew to $727301.0 in Q1 2026, from $619329.0 in the prior quarter.
• Over five years, Total Current Liabilities peaked at $2.3 million in Q4 2024 and troughed at $275041.0 in Q1 2025.
• A 5-year average of $1.3 million and a median of $1.3 million in 2022 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2025 — Total Current Liabilities sank 85.9% — and 2026, when it surged 164.43%.
• Tracing BFNH's Total Current Liabilities over 5 years: stood at $1.3 million in 2022, then jumped by 35.0% to $1.8 million in 2023, then gained by 26.52% to $2.3 million in 2024, then slumped by 73.1% to $619329.0 in 2025, then gained by 17.43% to $727301.0 in 2026.
• Business Quant data shows BFNH's Total Current Liabilities at $727301.0 in Q1 2026, $619329.0 in Q4 2025, and $500722.0 in Q3 2025.